SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Q2 results and a sharply reduced full-year revenue outlook tied to weaker Uber Eats volume and the planned end of the Uber partnership are driving attention, alongside analyst downgrades. Traders are divided between bullish hopes for Grubhub/DoorDash expansion, healthcare initiatives and a short squeeze, and bearish concerns over losses, cash burn, dilution and execution.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

Expectations of a Bitcoin pullback and weakness in MicroStrategy (MSTR) are driving interest in MSTZs leveraged inverse exposure. Traders are using it mainly for short-term bearish trades and hedges, while others warn that daily-reset decay and volatility make it unsuitable for long-term holding.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

Strong quarterly results and upbeat growth outlook are driving attention, with traders highlighting resilient order demand, DashPass adoption, and improving margins. Debate centers on whether the rally is justified given DoorDashs elevated valuation and risks from competition, AI disintermediation, and execution costs.

Cash Cat

Robinhoods listing of Cash Cat on its main app has driven intense attention, with traders framing it as a flagship Robinhood-chain meme token supported by fee-funded buybacks and burns. The community is divided between bullish holders expecting broader adoption and continued momentum, and skeptics citing post-listing profit-taking, high spreads, volatility, and possible manipulation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish short report questioning SELLASs REGAL Phase 3 trial design, statistical power, and valuation triggered the latest attention and selloff. Traders remain divided, with bulls dismissing it as a short-side thesis while bears point to the delayed 80th event and the binary uncertainty surrounding the eventual readout.

American Superconductor Corp. engages in the provision of megawatt-scale power solutions. Its products include electric control systems, generators & drivetrains, power converters, renewable interconnectivity solutions, software, turbine designs, utility and industrial resilience and modernization solutions, and utility voltage solutions. It operates through the Grid and Wind segments. The Grid segment enables electric utilities and renewable energy project developers to connect, transmit, and distribute power with efficiency, reliability, security, and affordability. The Wind segment permits the manufacturers to field wind turbines with power output, reliability, and affordability. The company was founded by Yet Ming Chiang, David A. Rudman, John B. Vander Sande, and Gregory J. Yurek on April 9, 1987 and is headquartered in Ayer, MA.

American Superconductor Corp.

A recent quarterly update featuring record revenue, strong orders and an expanded backlog has focused attention on AMSCs grid-infrastructure, transformer and data-center demand. Traders remain divided, with bullish investors emphasizing growth and future contracts while others cite conservative guidance, margin pressure, an internal-control disclosure and the lack of a clearly announced data-center win as reasons for the selloff.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

SanDisks reported cancellation of its planned Michigan factory expansion, combined with concerns about intensifying Chinese NAND competition and an overextended memory-stock rally, is driving bearish positioning in SNDQ. Traders are actively using the 2x inverse ETF to hedge or scalp sharp SNDK swings, while others dispute the bearish thesis and favor long exposure to the underlying.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is surging toward new milestones, driven by sector-wide enthusiasm from major oncology vaccine developments and increasing anticipation for its upcoming prostate cancer BLA filing and upcoming clinical presentations.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

A strong quarterly earnings beat, record margin expansion, and raised full-year outlook have fueled attention around Corsairs turnaround, with traders highlighting improving profitability, gaming peripherals, and its emerging local-AI hardware strategy. The bullish reaction is amplified by short-interest and squeeze speculation, while some traders remain cautious about low volume, analyst downgrades, and the sustainability of the rally.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

Investors are drawing attention to SGOV as a cash-like, low-volatility parking place amid concerns about stretched equity valuations, recession risk, geopolitical uncertainty, and potentially higher-for-longer interest rates. The dominant discussion emphasizes capital preservation, liquidity, monthly Treasury income, and state-tax advantages, with some debate over dividend timing and whether alternatives such as BIL, USFR, or money-market funds offer better yields or fees.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pacer Funds Trust - Pacer Trendpilot International ETF

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$37.71
Prev Close	$37.80
Open	$37.94
Dividend Yield	N/A
50-Day Moving Average	$36.90
Beta	N/A
Avg. Volume	10,950.01
PE Ratio	N/A

52-Week High	$39.49
52-Week Low	$29.30
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info